Zoetis Inc
NYSE:ZTS
Zoetis Inc
EPS (Diluted)
Zoetis Inc
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Zoetis Inc
NYSE:ZTS
|
EPS (Diluted)
$5
|
CAGR 3-Years
12%
|
CAGR 5-Years
13%
|
CAGR 10-Years
17%
|
|
Johnson & Johnson
NYSE:JNJ
|
EPS (Diluted)
$15
|
CAGR 3-Years
41%
|
CAGR 5-Years
24%
|
CAGR 10-Years
12%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
EPS (Diluted)
-$3
|
CAGR 3-Years
-3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Pfizer Inc
NYSE:PFE
|
EPS (Diluted)
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck & Co Inc
NYSE:MRK
|
EPS (Diluted)
$0
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-5%
|
|
Eli Lilly and Co
NYSE:LLY
|
EPS (Diluted)
$6
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
7%
|
See Also
What is Zoetis Inc's EPS (Diluted)?
EPS (Diluted)
5.2
USD
Based on the financial report for Mar 31, 2024, Zoetis Inc's EPS (Diluted) amounts to 5.2 USD.
What is Zoetis Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
17%
Over the last year, the EPS (Diluted) growth was 17%. The average annual EPS (Diluted) growth rates for Zoetis Inc have been 12% over the past three years , 13% over the past five years , and 17% over the past ten years .